The fully self-contained laboratory tablet coating machine requires only power and compressed air to operate.
All contact parts are in 316L stainless steel, or US FDA approved materials.
The unit can be used for the development of coating processes, and also for marketing and colour matching.
The system uses a 5.7in colour touchscreen to control all operations. Heat recovery is available from all heat sources reducing energy requirements and exhaust air temperature.
Batch sizes for drum coating are from 4kg down to 400g, but there is an option to convert the system to a Wurster Column and coat batches down to 40g.
Maintenance is kept to a minimum with quick-release operator parts and push-in connectors that eliminate the need for special tools. Rapid strip down and re-assembly saves time between batches and all parts can be cleaned ultrasonically.
Tablet coating machine for small batches
The CSI Technicota LAB coats batches down to 40g when converted to a Wurster Column
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Read moreVirica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
Trending Articles
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering